Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Journal of Hepatology|August 22, 2019
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, Angiola Spinetti, Andrea Lombardi, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
Modern Rheumatology|December 25, 2018
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritisMarco Sebastiani, Laura Milazzo, Fabiola Atzeni, et al.
Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
Hepatology (Baltimore, Md.)|December 17, 2021
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohortLoreta A Kondili, Monica Monti, Maria Giovanna Quaranta, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 15, 2023
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward eliminationGiuseppina Brancaccio, Barbara Coco, Alessandra Nardi, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Hepatology Communications|November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort StudyLuca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
Pageof 24